SC
GBT

Siena Capital’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Siena Capital’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$0 Hold
4
– – ﹤0.01% 277
2022
Q2 		$0 Sell
4
-21
-84% -$615 ﹤0.01% 316
2022
Q1 		$1K Buy
+25
New +$747 ﹤0.01% 298

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Siena Capital's GBT Position: Q3 2022 in Review

Siena Capital held its Global Blood Therapeutics, Inc. (GBT) position steady in Q3 2022 at 4 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #277.

Siena Capital first reported a position in GBT in Q1 2022 and has held it in 3 quarters since. The position peaked at $1K in Q1 2022. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

  • Siena Capital held 4 shares of Global Blood Therapeutics, Inc. worth $0 as of Q3 2022.
  • Siena Capital left its Global Blood Therapeutics, Inc. share count unchanged in Q3 2022.
  • Global Blood Therapeutics, Inc. made up ﹤0.01% of Siena Capital's portfolio in Q3 2022, its #277 holding.
  • Siena Capital first reported a position in Global Blood Therapeutics, Inc. in Q1 2022 and has held it in 3 quarters since.
  • Siena Capital's Global Blood Therapeutics, Inc. position peaked at $1K in Q1 2022.
  • 247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on Siena Capital's 13F filing for Q3 2022, filed 2 Nov 2022.